According to Forbes, a small team of Israeli scientists are claiming that they are in the final stages of developing the world's first 'complete' cure for cancer.
The revolutionary cure, dubbed MuTaTo, is being developed by Accelerated Evolution Biotechnologies Ltd. and will apparently be available for cancer patients early next year.
The chairman of the company, Dan Aridor told The Jerusalem Times,
Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market. Our solution will be both generic and personal.
The scientists also claim that it will be cheap and effective and will have minimal side-effects.
MuTaTo reportedly uses a combination of cancer-targeting peptides and a unique toxin that only targets and terminates cancer cells. It leaves alone healthy cells and tissues in the process.
The Israeli scientists claim that that the cure can be hyper-personalised to each patient.
They have successfully conducted trials on mice and are now fast-tracking to conduct human trials through 2019.
If the trials complete successfully, it will save millions of lives in the coming years.